Last year, the sale of e-cigarettes containing nicotine without a legal license or prescription became an illegal activity. However, with e-cigarettes easier to obtain than ever before, illegal and non-prescription drug supplies are posing a threat to the public health success achieved in Australia over the past few decades.
According to a new report by the Cancer Council, the vast majority of Australians support taking action to better regulate the use of e-cigarettes.
A young woman smoking an electronic cigarette; image source: Moment RF / Getty Images.
Electronic cigarettes are becoming increasingly popular among young people due to their attractive odor and brightly colored packaging. However, their addictive nature lacks true attention.
Megan Varlow, the Cancer Control Policy Director of the Australian Cancer Council, stated that their approach was deliberately designed this way.
Therefore, their manufacturing methods are very appealing, as well as their marketing, fruity flavors, and interesting designs that attract young people. They have done an excellent job in spreading among peers and maintaining secrecy, almost ensuring access to illegal products without parents' knowledge.
A new study suggests that the vast majority of Australians support taking action to better regulate the use of electronic cigarettes.
A joint report by the Australian Cancer Council and Quit has revealed that 83% of Australians want both federal and state governments to crackdown on retailers illegally selling nicotine e-cigarettes without a valid prescription.
Dr. Sarah White, director of Quit Victoria, informed SBS News that the majority of e-cigarette users are young adults aged between 18 and 24.
We are deeply concerned about this because the smoking rate among ages 18-24 is actually very low. So this is a group that is reacting to culture rather than using e-cigarettes as a means of quitting smoking. When we see a quarter of people saying e-cigarettes are very addictive, we know and must reflect on the issues that arise from young people using e-cigarettes.
Statement:
This article has been compiled from third-party information and is intended solely for industry exchange and learning purposes.
This article does not represent the views of 2FIRSTS and they cannot confirm the truth or accuracy of its contents. The translation of this article is solely for industry communication and research purposes.
Due to limitations in translation ability, the compiled article may not fully express the same meaning as the original. Therefore, it is advised to refer to the original text for accuracy.
2FIRSTS maintains complete alignment with the Chinese government regarding any domestic issues, those related to Hong Kong, Macau, Taiwan, or foreign affairs.
The copyright of compiled information belongs to the original media and authors. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
